OriGene Tech Raises $16 Million

OriGene Technologies, a Rockville, Md.-based developer of monoclonal antibodies, has raised $16 million in Series B funding. New backers included IDG-Accel, SBI & TH Venture Capital Enterprise and Zero2IPO. Return participants were Morningside Venture Investments and President International Development Corp. The company also has operations in China.

North AmericaUSBriefs